Seth Bagshaw
Analyst · Stifel. Your line is now open
Thank you, John and I’ll cover our Q2 2019 financial results and discuss our Q3 2019 guidance. Sales in second quarter $474 million, an increase of 2% sequentially compared to the first quarter. Revenue was slightly under the midpoint of our Q2 guidance as seven sector market cause has left long expected. In addition our advanced market impacted by the Jones slowdown industrial markets which occurred in the latter the quarter, as well as uncertainty costs by global trade tension. 55% of our sales were customers in our advanced markets or 45% were customers in semiconductor market. This was long-term goal achieving balanced market mix. Sales for advanced markets were a record $260 million, an increase of 7% sequentially due to full quarters impact of the ESI acquisition. Sales for semiconductor customers were $214 million a decrease of 3% sequentially. Non-GAAP gross margin was 45% which was favorable to our expectations at this revenue volume due to product mix and continued cost controls. Non-GAAP operating expenses were $125 million, which was $7 million the above the midpoint of our guidance due to strong focus on managing our cost structure. Non-GAAP operating margin was 19%, which was 103 basis points favorable to the mid-point of our guidance range. A strong future performance reflects our ability to effectively manage the company through all phase of the operating cycle. GAAP gross margin was 44.5% included the impact of $2.5 million of inventory purchase accounting charges. GAAP operating expenses were $147 million, included $17.6 million in amortization of intangible assets, $3.2 million in acquisition integration costs, and $1.2 million in restructuring costs. GAAP net interest expense was $12.7 million, and non-GAAP net interest expense was $11.4 million. Our GAAP tax rate was 27%, and our non-GAAP tax rate was 23%. Tax rate were higher than expectations through the mix of geographic income. GAAP net income was $37.7 million or $0.69 per diluted share and non-GAAP net earnings were $59.9 million or $1.09 per diluted share. The integration of ESI acquisition continues to proceed very well exceeding the second quarter almost $7 million of annualized cost synergies. We are on target to realize a $50 million announced total synergies in 18 to 36 months subsequent to the transaction closing. In the second quarter revenue for the equipment and solutions division was $56 million and non-GAAP operating margin was approximately 16% ahead of our expectations at the sales volume due to favorable product mix and realization of cost synergies ahead of schedule. Now turning to the balance sheet. In June, we completed a $50 million voluntary prepayment on our term loan and at June 30 and are still down $947 million. Our goal continues to delever the balance sheet, lower interest costs. This most recent voluntary prepayment is our ninth since loan origination in April 2016. At the end of the quarter, we maintained a strong balance sheet and liquidity $460 million of cash and investments, $100 million of incremental borrowing capacity under an asset-based line of credit, a modest trailing 12-month net leverage ratio of under one times. Free cash flow for the quarter was $64 million [indiscernible] sales and increased $49 million in the first quarter of 2019. Free cash flow in the first quarter through the payments of ESI acquisition costs which closed on February 1. We continue to demonstrate a balanced approach to capital deployment. In the quarter, we paid a cash dividend of $10.9 million or $0.20 per share. In terms of working capital, days sales outstanding were 60 days at the end of the second quarter compared to 66 days on a pro forma basis at the end of the first quarter. Inventory turns were 2.2 times consistent with the first quarter on a pro forma basis. Finally, I’ll discuss our Q3 2019 guidance. Based on current business levels, we estimate our sales in the third quarter to range from $415 million to $465 million and a non-GAAP gross margin to range 43.5% to 45.5%. Q3 non-GAAP operating expenses could range from $122 million to $129.5 million, R&D expenses could range from $41.1 million to $44 million and SG&A expenses could range from $80.5 million to $85.5 million. Non-GAAP interest expense estimated to be approximately $10.8 million and non-GAAP tax rate to be approximately 22%. Given these assumptions, third quarter non-GAAP net earnings could range from $38.2 million to $56.6 million or $0.69 per share to $1.02 per diluted share. In the third quarter, amortization of tangible assets is expected to be approximately $17.2million,integration related costs is expected to approximately $1.7 million. Restructuring costs estimated at $1.8 million, interest income is expected $1.02 million and GAAP interest expense estimated to be approximately $1.6 million. GAAP net income at the range from $21.4 million to $39.8 million or $0.39 to $0.72 per diluted share on approximately 55.3 million shares outstanding. This concludes the prepared remarks. I will now open the call for questions.